Finance

Lists
Q3 2026 earnings • released • EPS beat +177.00% • Revenue beat +0.49%
See results
CLOV:NASDAQ
Clover Health Investments Corp
$4.82
+7.59%
(+0.34) 1D
$4.79
-0.61% (-0.030)
After hours
Closed: Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLOV...
Open
$4.42
High
$4.83
Low
$4.38
Mkt. cap
2.56B
Avg. vol.
4.33M
Volume
7.56M
52-wk high
$5.59
52-wk low
$1.58
EPS
-$0.04
Beta
2.52
Shares outstanding
435.44M
No. of employees
724
Open
$4.42
High
$4.83
Low
$4.38
Mkt. cap
2.56B
Avg. vol.
4.33M
Volume
7.56M
52-wk high
$5.59
52-wk low
$1.58
EPS
-$0.04
Beta
2.52
Shares outstanding
435.44M
No. of employees
724
News stories
From web sources and news partners
Profile
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021. Wikipedia
About Clover Health Investments Corp
CEOAndrew Toy
Employees724
FoundedJul 17, 2014
HeadquartersJersey City, New Jersey, United States
SectorHealth Care
IndustryHealth care provider
Websitecloverhealth.com
Analyst ratings
Based on 4 analysts giving stock ratings to CLOV in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CLOV in the last 3 months.
Highest
Current $4.82
$6.00 (+24.48%)
Average
$5.75 (+19.29%)
Lowest
$5.50 (+14.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Yong
UBS
Hold
Reiterated
$5.50
+14.1%
11/05/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
$5.50
+14.1%
11/05/2026
Matthew Shea
Needham
Buy
Initiated
$6.00
+24.5%
10/28/2026
George Hill
Deutsche Bank
Buy
Initiated
$6.00
+24.5%
09/11/2026
Whit Mayo
Leerink Partners
Hold
Maintained
$3.00
-37.8%
10/22/2025
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.03 / $0.01
+177.00%beat
Revenue / Est. (USD)
759.30M / 755.58M
+0.49%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
487.71M
749.19M
743.17M
759.30M
Cost of goods sold
413.50M
589.65M
590.16M
629.46M
Cost of revenue
413.50M
589.65M
590.16M
629.46M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
123.11M
131.69M
124.44M
122.80M
Operating expense
123.53M
132.21M
125.00M
123.41M
Total operating expenses
537.03M
721.86M
715.17M
752.87M
Operating income
-49.32M
27.33M
28.00M
6.44M
Other non operating income
-1.00K
-
-
-
EBT including unusual items
-49.32M
27.33M
28.00M
6.44M
EBT excluding unusual items
-49.32M
27.33M
28.00M
6.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-49.32M
27.33M
28.00M
6.44M
Net profit margin
-10.11%
3.65%
3.77%
0.85%
Earnings per share
-0.05
0.07
0.07
0.03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
420.00K
515.00K
564.00K
610.00K
EBITDA
-48.90M
27.85M
28.56M
7.04M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps